CTLT
$CTLT
Catalent, Inc.
Contract development and manufacturing organization providing drug delivery technologies.
HealthcareAnalyst Rating
Hold
0 Buy / 11 Hold / 3 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
CTLT Catalent: Contract Pharma Outlook
A balanced look at CTLT, highlighting Catalent's scale in CDMO services, stretched profitability with negative EPS, and a consensus Hold. This report lays out valuation, catalysts, and practical items for investors.
Apr 6, 2026